Health
Clinical Challenges: When to Add Immunotherapy in Breast Cancer – MedPage Today
Immune checkpoint inhibitors and other immunotherapies may soon have an expanded role
For breast cancer patients, the current indications for immune checkpoint inhibitors (ICIs) are generally limited to triple-negative breast cancer (TNBC), both in high-risk early-stage disease or in the advanced setting for tumors with certain levels of…
Continue Reading
-
Noosa News23 hours agoQueensland weather forecast sees sunny weather for last week of winter
-
Business21 hours agoWhy the Betashares Nasdaq 100 ETF could be a perfect buy and hold pick
-
General18 hours agoMigrants raise concerns over Australia’s English tests for visa applicants
-
General23 hours agoEnergy provider ENGIE to ‘correct’ electricity bills for thousands of South Australian customers